$1.16
0.032.65%
Last update: Nov 11, 11:36 AM
Palisade Bio Inc (PALI) Stock Price, Quote, News & History
PALINASDAQ
Palisade Bio missed Q3 loss estimates at 7¢/share. Shares rose 3.1% as analysts cut price targets; ASCENTRA trials advance.
You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.
Other companies in Palisade Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Palisade Bio has a consensus price target of $9.00.
The stock price for Palisade Bio (NASDAQ: PALI) is $1.16 last updated November 11, 2026 at 11:36 AM EST.
There are no upcoming dividends for Palisade Bio.
Palisade Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Palisade Bio.
Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and...
